Childrens Ibuprofen 572
- Product NDC
- 55319-929
- 11-digit product format
- 553190929
- Labeler code
- 55319
- Product ID
- 55319-929_3da7e78b-2397-42c5-8a9e-1dc9ae0afea4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ibuprofen
- Dosage form
- SUSPENSION/ DROPS
- Route
- ORAL
- Labeler
- Family Dollar Services, Inc.
- Application
- ANDA210149
- Marketing category
- ANDA
- Marketing start
- 2024-04-18
- Substance
- IBUPROFEN
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210149-001 | IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A210149-001 | IBUPROFEN | 100MG/5ML | SUSPENSION / ORAL | 2018-08-17 | f41ea6bd6efb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Childrens Ibuprofen 572
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WK2XYI10QM | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197803 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1a2182df-4339-442d-9c61-98c8b01e36fa | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55319-929-03 | Childrens Ibuprofen 572 | 120 mL in 1 BOTTLE | SUSPENSION/ DROPS | 120 | 2 | |
| 55319-929-03 | Childrens Ibuprofen 572 | 1 in 1 CARTON | SUSPENSION/ DROPS | 1 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197803 | ibuprofen 100 MG in 5 mL Oral Suspension | PSN | 1a2182df-4339-442d-9c61-98c8b01e36fa | 2 |
| 197803 | ibuprofen 20 MG/ML Oral Suspension | SCD | 1a2182df-4339-442d-9c61-98c8b01e36fa | 2 |
| 197803 | ibuprofen 100 MG per 5 ML Oral Suspension | SY | 1a2182df-4339-442d-9c61-98c8b01e36fa | 2 |
| 197803 | ibuprofen 200 MG per 10 ML Oral Suspension | SY | 1a2182df-4339-442d-9c61-98c8b01e36fa | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55319-929-03 | 55319092903 | 1 BOTTLE in 1 CARTON (55319-929-03) / 120 mL in 1 BOTTLE | 1 bottle | 2024-04-18 | No | No | Current |